(Q30590874)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jianxun Ding

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Chaoliang He

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Yu Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Mingqiang Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jie Chen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Xiuli Zhuang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Xuesi Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

18 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

Macromolecular Bioscience

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

584-594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23420692%20AND%20SRC:MED&resulttype=core&format=json

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Biodegradable nanoparticles for drug and gene delivery to cells and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: concepts and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Biodegradable block copolymer-doxorubicin conjugates via different linkages: preparation, characterization, and in vitro evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Hyperbranched double hydrophilic block copolymer micelles of poly(ethylene oxide) and polyglycerol for pH-responsive drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Camptothecin delivery methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Camptothecin derivative-loaded poly(caprolactone-co-lactide)-b-PEG-b-poly(caprolactone-co-lactide) nanoparticles and their biodistribution in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Development of thermosensitive poly(n-isopropylacrylamide-co-((2-dimethylamino) ethyl methacrylate))-based nanoparticles for controlled drug release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Novel nanogels as drug delivery systems for poorly soluble anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Preparation and cytotoxic activity of poly(ethylene glycol)-modified poly(amidoamine) dendrimers bearing adriamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Dendrimers as carriers for delivery of chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441

Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201200441